Sanofi (SNY) News Today $51.99 -0.40 (-0.76%) Closing price 04:00 PM EasternExtended Trading$51.98 -0.02 (-0.03%) As of 06:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why is Sanofi Down Today?Sanofi (SNY) stock has climbed on a wave of favorable regulatory, operational, and strategic news that bolster its vaccine and oncology franchises. FDA label expansion for MenQuadfi approved, extending use of its quadrivalent meningococcal vaccine to infants as young as 6 weeks—the first MenACWY shot for this age group, opening a key pediatric segment. Sanofi and Vietnam Vaccine JSC (VNVC) officially launch a new vaccine manufacturing facility in Vietnam, boosting production capacity for domestic and export markets. Completion of the acquisition of DR-0201, a targeted bispecific myeloid cell engager from Dren Bio, enhances Sanofi’s oncology pipeline. Triggered €8 million milestone payment to C4X Discovery for advancement of its oral IL-17A inhibitor program, underscoring successful partnerships. Short interest in Sanofi shares remains negligible, reflecting little bearish positioning by investors. A Wall Street analyst reaffirmed a hold on Vigil Neuroscience amid Sanofi’s acquisition of VG-3927 rights, though direct impact on SNY is limited. Posted 2h agoAI Generated. May Contain Errors. SNY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Sanofi granted FDA label expansion for MenQuadfi meningococcal shot for infantsMay 28 at 2:10 PM | msn.comBrucke Financial Inc. Invests $470,000 in Sanofi (NASDAQ:SNY)Brucke Financial Inc. purchased a new position in shares of Sanofi (NASDAQ:SNY - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 9,739 shares of the company's stock,May 28 at 7:14 AM | marketbeat.comPolar Asset Management Partners Inc. Has $1.51 Million Stock Position in Sanofi (NASDAQ:SNY)Polar Asset Management Partners Inc. reduced its holdings in shares of Sanofi (NASDAQ:SNY - Free Report) by 43.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 31,400 shares of the company's stock after selling 2May 28 at 5:36 AM | marketbeat.comSanofi (SNY)’s MenQuadfi Becomes First MenACWY Vaccine Approved for Ages 6 Weeks and UpMay 27 at 9:28 PM | insidermonkey.comSanofi, VNVC Launch Vaccine Manufacturing Facility In Vietnam, Says Report: Retail’s PositiveMay 27 at 5:40 PM | msn.comHold Rating on Vigil Neuroscience Amid Sanofi Acquisition and VG-3927 DevelopmentsMay 27 at 9:12 AM | tipranks.comUS FDA approves use of Sanofi's meningococcal vaccine in infantsMay 27 at 7:37 AM | reuters.comSanofi: Sanofi completes acquisition of DR-0201May 27 at 5:55 AM | finanznachrichten.deGF Fund Management CO. LTD. Takes Position in Sanofi (NASDAQ:SNY)GF Fund Management CO. LTD. acquired a new position in shares of Sanofi (NASDAQ:SNY - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 6,322 shares of the company's stock, valued at approximately $305,000. Other hedge funds hMay 27 at 5:14 AM | marketbeat.comFocus Partners Advisor Solutions LLC Invests $502,000 in Sanofi (NASDAQ:SNY)Focus Partners Advisor Solutions LLC bought a new position in shares of Sanofi (NASDAQ:SNY - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund bought 10,414 shares of the company's stock, valued at approximately $502,000. Other large investors also rMay 27 at 4:56 AM | marketbeat.comC4X Discovery receives latest milestone payment from SanofiMay 27 at 3:00 AM | globenewswire.comSanofi, VNVC launch vaccine factory in VietnamMay 27 at 2:17 AM | reuters.comPress Release: Sanofi completes acquisition of DR-0201May 27 at 1:00 AM | globenewswire.comSanofi (SNY) Secures Key Role in $10B France-Vietnam AgreementsMay 26 at 12:40 PM | gurufocus.comForum Financial Management LP Purchases 28,879 Shares of Sanofi (NASDAQ:SNY)Forum Financial Management LP boosted its holdings in Sanofi (NASDAQ:SNY - Free Report) by 76.1% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 66,827 shares of the company's stock after buying an addiMay 26 at 7:21 AM | marketbeat.comParr Mcknight Wealth Management Group LLC Invests $1.57 Million in Sanofi (NASDAQ:SNY)Parr Mcknight Wealth Management Group LLC bought a new stake in Sanofi (NASDAQ:SNY - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 32,646 shares of the company's stock, valued at approximateMay 26 at 5:43 AM | marketbeat.comBarrow Hanley Mewhinney & Strauss LLC Has $371.24 Million Stock Position in Sanofi (NASDAQ:SNY)Barrow Hanley Mewhinney & Strauss LLC reduced its position in Sanofi (NASDAQ:SNY - Free Report) by 1.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 7,697,289 shares of the company's stock after sellingMay 25 at 6:20 AM | marketbeat.comKey deals this week: Foxconn, Sanofi, Honeywell, Adriatic Metals, Informatica and moreMay 24, 2025 | msn.comPharma Stock Roundup: NVO CEO Resigns, SNY to Buy VIGL & MoreMay 23, 2025 | msn.comAnalysts Think These Stocks Could More Than Double in Value (SNY)Septerna, Intellia, and Novavax have garnered investor attention for their significant upside potential, but investors should beware the risks as well.May 23, 2025 | marketbeat.comSanofi opens new, $130 million NJ offices in Morristown, showcasing innovative, modern design and strengthening US presenceMay 22, 2025 | prnewswire.comVigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by SanofiMay 22, 2025 | msn.comSanofi to buy Vigil Neuroscience in $470M deal (update)May 22, 2025 | msn.comVentyx Biosciences: Strategic Investment by Sanofi Highlights Promising Prospects and Innovative ApproachMay 22, 2025 | tipranks.comSanofi Boosts Alzheimer's Pipeline With Vigil Neuroscience AcquisitionMay 22, 2025 | benzinga.comSanofi (NASDAQ:SNY) Stock Position Lifted by Zimmer Partners LPZimmer Partners LP boosted its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 21.3% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 488,300 shares of the company's stock after purchasing an additional 85,800 shares during tMay 22, 2025 | marketbeat.comSnowden Capital Advisors LLC Sells 5,023 Shares of Sanofi (NASDAQ:SNY)Snowden Capital Advisors LLC lowered its position in Sanofi (NASDAQ:SNY - Free Report) by 19.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 20,699 shares of the company's stock after selling 5,023 shares during the period. Snowden Capital AdvMay 22, 2025 | marketbeat.comSanofi (NASDAQ:SNY) Shares Sold by Royal Bank of CanadaRoyal Bank of Canada cut its position in shares of Sanofi (NASDAQ:SNY - Free Report) by 2.1% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,392,488 shares of the company's stock after selling 51,511 shares during the quarter. Royal Bank ofMay 22, 2025 | marketbeat.comSanofi Set to Acquire Vigil Neuroscience in $470 Million DealMay 21, 2025 | insidermonkey.comNovavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone PaymentMay 21, 2025 | benzinga.comSanofi Set to Acquire Vigil Neuroscience in $470 Million DealMay 21, 2025 | msn.comSanofi to buy Vigil Neuroscience in $470M deal, adding Alzheimer’s treatment to pipelineMay 21, 2025 | msn.comSanofi to Buy Vigil Neuroscience for About $470 MillionMay 21, 2025 | wsj.comSanofi to Acquire Vigil Neuroscience for Up to $10.00 per Share in Cash; Transaction Expected to Enhance Alzheimer’s Drug DevelopmentMay 21, 2025 | quiverquant.comSanofi to acquire Vigil Neuroscience in $470 million dealMay 21, 2025 | reuters.comPress Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer's disease to the neurology pipelineMay 21, 2025 | globenewswire.comVestal Point Capital LP Acquires 600,000 Shares of Sanofi (NASDAQ:SNY)Vestal Point Capital LP increased its holdings in Sanofi (NASDAQ:SNY - Free Report) by 400.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 750,000 shares of the company's stock after purchasing an additional 600,000 shares during theMay 21, 2025 | marketbeat.comViz.ai Announces Collaboration With Sanofi and Regeneron to Improve Management and Care of Chronic Obstructive Pulmonary Disease (COPD)May 20, 2025 | businesswire.comSanofi (NASDAQ:SNY) Shares Acquired by Tang Capital Management LLCTang Capital Management LLC raised its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 285.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 270,000 shares of the company's stock after acquiringMay 20, 2025 | marketbeat.comNovavax shares surge on FDA vaccine approvalMay 19, 2025 | investing.comSuvretta Capital Management LLC Sells 43,400 Shares of Sanofi (NASDAQ:SNY)Suvretta Capital Management LLC reduced its holdings in shares of Sanofi (NASDAQ:SNY - Free Report) by 24.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 131,501 shares of the company's stock after selling 43,400 sharMay 19, 2025 | marketbeat.comSanofi (NASDAQ:SNY) Holdings Cut by Polar Asset Management Partners Inc.Polar Asset Management Partners Inc. cut its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 43.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 31,400 shares of the company's stock after selling 24,100 shares duMay 19, 2025 | marketbeat.comCresset Asset Management LLC Has $292,000 Stock Position in Sanofi (NASDAQ:SNY)Cresset Asset Management LLC trimmed its holdings in shares of Sanofi (NASDAQ:SNY - Free Report) by 88.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,058 shares of the company's stock after selling 44,579 shares durinMay 19, 2025 | marketbeat.comSphera Funds Management LTD. Reduces Stock Holdings in Sanofi (NASDAQ:SNY)Sphera Funds Management LTD. reduced its holdings in Sanofi (NASDAQ:SNY - Free Report) by 6.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 384,515 shares of the company's stock after selling 25,0May 18, 2025 | marketbeat.comPoint72 Asset Management L.P. Grows Stock Position in Sanofi (NASDAQ:SNY)Point72 Asset Management L.P. increased its stake in Sanofi (NASDAQ:SNY - Free Report) by 969.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 950,649 shares of the company's stock after buying an addMay 18, 2025 | marketbeat.comBerenberg Bank Keeps Their Buy Rating on Sanofi (SNYNF)May 18, 2025 | theglobeandmail.comQuantinno Capital Management LP Buys 68,444 Shares of Sanofi (NASDAQ:SNY)Quantinno Capital Management LP raised its stake in Sanofi (NASDAQ:SNY - Free Report) by 69.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 167,320 shares of the company's stock after acquiring an additional 68,May 18, 2025 | marketbeat.comPathstone Holdings LLC Raises Stock Position in Sanofi (NASDAQ:SNY)Pathstone Holdings LLC grew its holdings in Sanofi (NASDAQ:SNY - Free Report) by 22.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 206,895 shares of the company's stock after acquiring an additional 37,937May 18, 2025 | marketbeat.comNuveen Asset Management LLC Acquires 34,660 Shares of Sanofi (NASDAQ:SNY)Nuveen Asset Management LLC boosted its position in shares of Sanofi (NASDAQ:SNY - Free Report) by 1.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,676,224 shares of the company's stMay 18, 2025 | marketbeat.comFocus Partners Wealth Has $3.48 Million Stake in Sanofi (NASDAQ:SNY)Focus Partners Wealth lifted its holdings in Sanofi (NASDAQ:SNY - Free Report) by 8.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 71,808 shares of the company's stock after pMay 18, 2025 | marketbeat.com Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address SNY Media Mentions By Week SNY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNY News Sentiment▼0.991.03▲Average Medical News Sentiment SNY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNY Articles This Week▼3616▲SNY Articles Average Week Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NVO News NVS News AZN News GSK News TAK News ARGX News ONC News BNTX News TEVA News SMMT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SNY) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe biggest threat isn’t ChinaWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe trade war twist nobody saw comingThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
